Caplin Point Laboratories Ltd KYS Report: Ownership & Insights

15:59 Dec 12

Caplin Point Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1963.90

+11.90 (+0.61%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Caplin Point Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Dec 12

1963.90

+11.90 (+0.61%)

71/100 High Financial Strength

Quality

37/100 Mid Valuation

Valuation

42/100 Technically Neutral

Technical

SWOT

Strength

Weakness

Opportunity

Threat

14.93K

Market Cap (Cr)

25.35

PE Ratio

4.73

Price to Book Ratio

RSI

27.68 %

Net Profit Margin

Rating Based on 2 Analysts

Buy 100%

Hold 0%

Sell 0%

Buy

The consensus recommendation from 2 analysts for Caplin Point Laboratories Ltd. is Buy

Analyst Price Target

The average price target is 2397 with a high estimate of 2499 and low estimate of 2295

High Average Low

Current 1963.90

2499.00

2397.00

2295.00

Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password